Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. TVGNW
TVGNW logo

TVGNW News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TVGNW News

TEVOGEN BIO HOLDINGS INC - AGREEMENT MAY TRANSFORM TEVOGEN INTO A PROFITABLE HEALTHCARE BUSINESS

Feb 26 2026moomoo

TEVOGEN ENTERS LETTER OF INTENT TO ASSESS POSSIBLE ACQUISITION OF SCIOMETRIX AND ITS DIGITAL CARE MANAGEMENT PLATFORM, CLINICUS

Feb 26 2026moomoo

TEVOGEN BOARD CONSIDERS POSSIBLE ONE-TIME SPECIAL CASH DIVIDEND FOR SHAREHOLDERS

Jan 30 2026moomoo

Tevogen Addresses Financial Report, Emphasizing Robust Capital Efficiency and Minimal Cash Burn

Nov 03 2025Newsfilter

Tevogen Executives Connect with Business and Community Leaders to Showcase Recent Achievements

Oct 29 2025Newsfilter

Tevogen Provides Update on TVGN 489 Amid Increasing Interest from Long COVID Patients

Oct 15 2025Newsfilter

Tevogen Achieves Significant Progress in AI Efforts to Improve T Cell–Based Therapies with 100x Expansion of PredicTcell™ Beta Data

Sep 25 2025Newsfilter

Tevogen Praises HHS for Tackling Long COVID, Highlights TVGN 489's Potential Benefits for 20 Million Americans

Sep 19 2025Newsfilter

TVGNW Events

No data

No data

TVGNW Monitor News

No data

No data

TVGNW Earnings Analysis

No Data

No Data

People Also Watch